Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

CHIEF ACCOUNTING OFFICER Megna Michael R exercised 20,627 units of Class A Ordinary Share at a strike of $9.56, covered exercise/tax liability with 4,657 units of Class A Ordinary Share and sold $383,240 worth of Class A Ordinary Share (11,000 units at $34.84), increasing direct ownership by 15% to 38,011 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.